Telix signs distribution agreement with Turkish firm

By staff writers

July 3, 2019 -- Telix Pharmaceuticals has signed a distribution agreement with Eczacıbaşı-Monrol of Istanbul.

Under the agreement, Eczacıbaşı-Monrol will be a radiopharmaceutical production partner and distributor for Telix in Turkey, the Middle East, and North Africa. The two firms will initially focus on developing TLX250-CDx (Zr-89 girentuximab) for PET imaging of renal cell carcinoma, according to Telix.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking